Add like
Add dislike
Add to saved papers

GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.

The gene associated with retinoid-interferon-induced mortality-19 (GRIM-19) has been identified as a tumor suppressor in many human cancers. However, little is known about the role of GRIM-19 in cutaneous squamous cell carcinoma (CSCC). Here, we aimed to investigate the potential function of GRIM-19 in CSCC and explore the underlying molecular mechanisms. We found that GRIM-19 protein and transcript levels were significantly decreased in CSCC cell lines. Overexpression of GRIM-19 suppressed the proliferation and invasion of CSCC cells, whereas knockdown of GRIM-19 promoted the proliferation and invasion of CSCC cells. Also, we found that overexpression of GRIM-19 inhibited the phosphorylation and transcription activity of the signal transducer and activator of transcription 3 (STAT3). Overexpression of GRIM-19 also suppressed the expression of STAT3 target genes, including cyclin D1, Bcl-2 and metal matrix proteinase 2. By contrast, knockdown of GRIM-19 showed the opposite effect. Moreover, suppression of STAT3 significantly attenuated the effect of GRIM-19 knockdown on induction of proliferation, invasion, and STAT3 target genes in CSCC cells. Taken together, our data show that GRIM-19 suppresses the proliferation and invasion of CSCC cells associated with downregulation of STAT3 signaling, suggesting a tumor suppressive role of GRIM-19 in CSCC. Our study suggests that decreased expression of GRIM-19 may contribute to the development and progression of CSCC and that GRIM-19 may serve as a potential therapeutic target for CSCC treatment.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app